Nearly two thirds of the 18 million new cancer patients each year fail treatment due to resistance that is not fully understood. Even in state-of-the-art clinical trials, oncologists struggle to select patients who are most likely to respond to specific therapies, because tools used to identify biomarkers and measure cancer resistance are outdated, imprecise, and expensive. At Aperture Bio, our single-cell proteomics technology generates rapid biomarker readouts from the most minute and fragile samples, unlocking the tumor immune environment to bring more effective therapies to market, faster.
Aperture Bio
Alumni Launch Lab
Aperture Bio
Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
About Aperture Bio
Term
2023-24 Academic Year
School
Harvard Medical School, Harvard Business School
Programs
Launch Lab X GEO
Connect
Awards & Affiliations
More Alumni Launch Lab Ventures
-
Growbie
Creating a networking bootcamp for international students building careers in the United States.
![Growbie team lead]()
-
Unlock Education
Empowering public schools to leverage the data they already have to drive their decisions.
![Unlock Education team leads]()
-
LivXp AG
Giving sports fans a chance to create lifetime memories through access to interactive experiences from their favorite teams and idols.
![LivXp team leads]()
-
Gridbrid
Helping companies simplify the process, maximize the profits, and reduce the risks of developing renewable energy power plants.
![GridBid team leads]()
Calling All Harvard Alumni
We welcome alumni to explore our ecosystem by attending events, connecting with fellow alumni in the space, and signing up for updates.
